PATENT CLAIM ANALYSIS

Application Number: 15940133
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "235200"]

Abstract:
Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.

Claim (Index 14):
The compound of  claim 13 , wherein R 10  is methyl or methoxy.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 90.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12950764', '13262888', '14658736', '14431935', '13821195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7600992459129312
- 35 USC 102 Novelty (BERT): 0.4991885746891689
- Combined Prediction Score: 0.734008178790555
- Mean Citation Score: 195.95137800000003
- Max Citation Score: 197.04544
- Similarity Product: 125.35625908737184

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test